U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06854263) titled 'CLARITY Study - PMCF Study' on Feb. 20.
Brief Summary: In the context of the Post-Market Clinical Follow-up (PMCF), this study aimed at evaluating the safety and performance of the RADSAFE(R) inks in the marking of the radiation field.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Radiation Site Marking Prior to Radiation Therapy
Intervention:
DEVICE: skin marking for radiotherapy treatment
skin marking for radiotherapy treatment
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Laboratoires BIOTIC Phocea
Published by HT Digital Content Services with permission from Health Daily Digest....